Who we work with, and how
The organizations helping us shape DNA storage in the real world, shown here as technology references and pilot engagements: valued collaborators today.
Organizations across government, defense, and industry are exploring what DNA Storage can do in their own environment, an early signal of where sovereign data protection matters most
SICPA
Project
Exploration of DNA for an anti-counterfeiting use case (tagging barcodes encoded in DNA on protected items)
Benefits
Assessed the feasibility and relevance of the tagging solution (leading to the strategic decision to focus on storage); joint patent filing with SICPA.
CNES
Project
Evaluation of the resistance of written and stored DNA to gamma radiation, with the goal of assessing the solution's potential for a Space use case
Benefits
Funding of dedicated stress tests; entry point to Thales, a global electronics leader.
Bordeaux Metropole
Project
Feasibility study of the DNA storage solution through a first end-to-end demonstrator
Benefits
Scaling up the size of processed files; entry point to major metropolitan authorities.
French Ministry of the Armed Forces
(Future Combat Command & Defence Digital Directorate)
Project
Evaluation of Biomemory's DNA writing, storage, and reading technology in an operational context
Benefits
Potential entry point to become an official supplier to the Armed Forces; evaluation of specific field use cases.
Technology partners
Scality is our first software platform partner. A global leader in data infrastructure software for AI-era storage at scale, Scality builds software-defined S3 object storage designed to span and optimize across multiple storage media, which is precisely the control plane DNA archives need to reach production.
Under the strategic partnership announced in June 2026, which also brought Scality CEO Jerome Lecat onto Biomemory's board of directors, the two companies are jointly developing a roadmap to integrate Biomemory DNA storage as a new, ultra-secure cold archive tier within Scality-managed environments, including Scality ADI.
For Biomemory this is both a technology partnership and a sales channel: Scality carries DNA archives into the enterprise, government and service provider accounts it already serves, alongside our own direct sales.
Investors
Molecular IT moves your critical information into synthetic DNA, giving enterprise IT a durable, offline layer that lasts for decades and beyond, needs almost no energy or space, and stays beyond attackers' reach. Next comes molecular computing, where billions of operations can run inside a single drop, taking on problems that stall today's processors in a far smaller footprint and at a fraction of the power.
Biomemory builds this layer. We were spun out of Sorbonne University and the CNRS, we operate in Paris and Boston, and our first offering is now open for Early Access. We co-chair the DNA Data Storage Alliance.
Backed by BPI France, Credit Mutuel, and Blast.
The Opportunity
Data is growing faster than the media built to hold it, and the data that matters most is the hardest to keep safe.
DNA is a new layer in the IT stack, beyond silicon: enormous capacity in almost no space, held for decades, with no power at rest and no network for an attacker to reach.
DNA takes share of large, established markets: cold storage, enterprise archiving, and data security. Together these are worth tens of billions of dollars today and head toward the hundreds of billions within a decade.
The DNA category inside them is early and growing fast, with serious capital and several players moving in.
Biomemory’s near-term focus is the security and archive segments.
Storage is the first market. Molecular computing is the next.
Institutional partnerships
Biomemory’s origin and support: CNRS, Sorbonne University, Agoranov, i-Lab, ADEME, i-Demo and France 2030.
Standards bodies
Biomemory is a leader in commercial DNA data storage and is a member of the DNA Data Storage Alliance, a SNIA Community. Biomemory's representative Vincent Franceschini is the current co-chair of the DDSA, and Chairman Emeritus of SNIA.
